Literature DB >> 8711673

Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges.

O Vandenplas1, J P Delwiche, J Jamart, R Van de Weyer.   

Abstract

BACKGROUND: Specific bronchial reactivity to occupational agents may decline after exposure in the workplace ceases leading to falsely negative specific inhalation challenges. A study was carried out to assess prospectively whether increases in nonspecific bronchial hyperresponsiveness could be useful in detecting the bronchial response to occupational agents during specific inhalation challenges.
METHODS: Specific inhalation challenges were performed in 66 subjects with possible occupational asthma due to various agents. After a control day the subjects were challenged with the suspected agent for up to two hours on the first test day. Those subjects who did not show an asthmatic reaction were rechallenged on the next day for 2-3 hours. The provocative concentration of histamine causing a 20% fall (PC20) in the forced expiratory volume in one second (FEV1) was assessed at the end of the control day as well as six hours after each challenge that did not cause a > or = 20% fall in FEV1. The subjects who had a significant (> or = 3.1-fold) reduction in PC20 value at the end of the second challenge day were requested to perform additional specific inhalation challenges.
RESULTS: The first test day elicited an asthmatic reaction in 25 subjects. Of the other 41 subjects five (12%, 95% confidence interval (CI) 4% to 26%) exhibited a > or = 3.1-fold fall in the PC20 value after the inhalation challenge and developed an asthmatic reaction during the second (n = 3) or third (n = 2) challenge exposure. The offending agents included persulphate (n = 1), wood dust (n = 2), isocyanate (n = 1), or amoxycillin (n = 1). These five subjects had left their workplace for a longer period (mean (SD) 21 (14) months) than those who reacted after the first specific inhalation challenge (8 (11) months).
CONCLUSIONS: The increase in non-specific bronchial hyperresponsiveness after a specific inhalation challenge can be an early and sensitive marker of bronchial response to occupational agents, especially in subjects removed from workplace exposure for a long time. Non-specific bronchial hyperresponsiveness should be systematically assessed after specific inhalation challenges in the absence of changes in airway calibre.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8711673      PMCID: PMC473590          DOI: 10.1136/thx.51.5.472

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  30 in total

1.  Bronchial provocation tests in etiologic diagnosis and analysis of asthma.

Authors:  J Pepys; B J Hutchcroft
Journal:  Am Rev Respir Dis       Date:  1975-12

2.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

3.  Prevalence of occupational asthma due to latex among hospital personnel.

Authors:  O Vandenplas; J P Delwiche; G Evrard; P Aimont; X van der Brempt; J Jamart; L Delaunois
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

Review 4.  Definition and diagnosis of occupational asthma.

Authors:  A Cartier
Journal:  Eur Respir J       Date:  1994-01       Impact factor: 16.671

5.  Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber.

Authors:  A Cartier; N C Thomson; P A Frith; R Roberts; F E Hargreave
Journal:  J Allergy Clin Immunol       Date:  1982-09       Impact factor: 10.793

6.  Time course of the increase in airway responsiveness associated with late asthmatic reactions to toluene diisocyanate in sensitized subjects.

Authors:  C E Mapp; R Polato; P Maestrelli; D J Hendrick; L M Fabbri
Journal:  J Allergy Clin Immunol       Date:  1985-05       Impact factor: 10.793

7.  Toluene diisocyanate-induced asthma without airway hyperresponsiveness.

Authors:  C E Mapp; L Dal Vecchio; P Boschetto; N De Marzo; L M Fabbri
Journal:  Eur J Respir Dis       Date:  1986-02

8.  Occupational asthma without bronchial hyperresponsiveness.

Authors:  F E Hargreave; E H Ramsdale; S O Pugsley
Journal:  Am Rev Respir Dis       Date:  1984-09

9.  Occupational asthma in snow crab-processing workers.

Authors:  A Cartier; J L Malo; F Forest; M Lafrance; L Pineau; J J St-Aubin; J Y Dubois
Journal:  J Allergy Clin Immunol       Date:  1984-09       Impact factor: 10.793

10.  Bronchial hyperresponsiveness and toluene diisocyanate. Long-term change in sensitized asthmatic subjects.

Authors:  P L Paggiaro; B Vagaggini; F L Dente; E Bacci; L Bancalari; M Carrara; A Di Franco; D Giannini; C Giuntini
Journal:  Chest       Date:  1993-04       Impact factor: 9.410

View more
  5 in total

1.  When should specific occupational challenge tests be performed?

Authors:  Susan M Tarlo
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 2.  Review of Diagnostic Challenges in Occupational Asthma.

Authors:  Jacques A Pralong; Andre Cartier
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

3.  Non-invasive tools beyond lung function before and after specific inhalation challenges for diagnosing occupational asthma.

Authors:  Julia Engel; Vera van Kampen; Vitali Gering; Olaf Hagemeyer; Thomas Brüning; Monika Raulf; Rolf Merget
Journal:  Int Arch Occup Environ Health       Date:  2019-05-29       Impact factor: 3.015

4.  Diagnosis and prevention of diseases induced by isocyanate.

Authors:  Kazuko Nakashima; Tatsuya Takeshita; Kanehisa Morimoto
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

5.  Asthma related to cleaning agents: a clinical insight.

Authors:  Olivier Vandenplas; Vinciane D'Alpaos; Geneviève Evrard; Jacques Jamart; Joel Thimpont; François Huaux; Jean-Christophe Renauld
Journal:  BMJ Open       Date:  2013-09-19       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.